Drug Delivery Devices

Drug Delivery Devices Market by Route of Administration (Inhalation, Injectable, Nasal), Vehicles (Dendrimer, Hydrogel, Liposome), Application, End-user - Global Forecast 2024-2030

SKU
MRR-B812DD5799B4
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 227.44 billion
2030
USD 470.38 billion
2024
USD 250.23 billion
CAGR
10.93%
360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the drug delivery devices market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[193 Pages Report] The Drug Delivery Devices Market size was estimated at USD 227.44 billion in 2023 and expected to reach USD 250.23 billion in 2024, at a CAGR 10.93% to reach USD 470.38 billion by 2030.

Drug Delivery Devices Market
To learn more about this report, request a free PDF copy
The drug delivery devices represent a broad spectrum of technology aimed at the efficient administration of medications for therapeutic outcomes. This market encompasses a wide range of instruments, apparatus, and technologies dedicated to administering pharmaceutical compounds to achieve a therapeutic outcome in humans or animals. The need for these devices is driven by the uptick in chronic illnesses, an aging population, advancements in delivery technologies, and a preference for less invasive methods. The surge in biologics and the focus on nanotechnology and regenerative medicine offer substantial support for market growth. In addition, the emergence of biologics, nanotechnology, and strategic alliances are boosting the growth of this sector. However, challenges such as regulatory barriers, patient safety concerns, and high development costs can impede progress. The market is poised for transformative growth, emphasizing research in biocompatibility, 3D printing, and sensor-based adherence tracking through collaboration and cutting-edge technological integration and the development of targeted therapies, sustained-release technologies, and smart devices that tailor treatment to individual needs.
Drug Delivery Devices Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Drug Delivery Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug Delivery Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Drug Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Antares Pharma, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Eisai Co., Ltd., Enable Injections, Inc., Gerresheimer AG, GlaxoSmithKline PLC, Insulet Corporation, Koninklijke Philips N.V., OraSure Technologies, Inc., Smiths Medical, Inc., and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Route of Administration
    • Inhalation
    • Injectable
    • Nasal
    • Ocular
    • Oral
    • Topical
    • Transdermal
  • Vehicles
    • Dendrimer
    • Hydrogel
    • Liposome
    • Mesoporous Material
    • Micelle
    • Nanoparticle
    • Niosomes
    • Scaffold
  • Application
    • Autoimmune Diseases
    • Cardiovascular Diseases
    • Central Nervous System Disorders
    • Diabetes
    • Infectious Diseases
    • Oncology
    • Respiratory Diseases
  • End-user
    • Ambulatory Surgery Centers/Clinics
    • Diagnostic Centers
    • Home Care Settings
    • Hospitals

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Drug Delivery Devices Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug Delivery Devices Market?
  3. What are the technology trends and regulatory frameworks in the Drug Delivery Devices Market?
  4. What is the market share of the leading vendors in the Drug Delivery Devices Market?
  5. Which modes and strategic moves are suitable for entering the Drug Delivery Devices Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Drug Delivery Devices Market, by Route of Administration
  7. Drug Delivery Devices Market, by Vehicles
  8. Drug Delivery Devices Market, by Application
  9. Drug Delivery Devices Market, by End-user
  10. Americas Drug Delivery Devices Market
  11. Asia-Pacific Drug Delivery Devices Market
  12. Europe, Middle East & Africa Drug Delivery Devices Market
  13. Competitive Landscape
  14. Competitive Portfolio
  15. List of Figures [Total: 24]
  16. List of Tables [Total: 404]
  17. List of Companies Mentioned [Total: 15]
Frequently Asked Questions
  1. How big is the Drug Delivery Devices Market?
    Ans. The Global Drug Delivery Devices Market size was estimated at USD 227.44 billion in 2023 and expected to reach USD 250.23 billion in 2024.
  2. What is the Drug Delivery Devices Market growth?
    Ans. The Global Drug Delivery Devices Market to grow USD 470.38 billion by 2030, at a CAGR of 10.93%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.